Home / Contract Awards / SAIC Inks SPAWAR Deal with Navy

SAIC Inks SPAWAR Deal with Navy

SAIC (NYSE: SAI) has won a prime contract from the Space and Naval Warfare Systems Command (SPAWAR) to provide systems engineering and technical support services to the Navy Tactical Mobile (TacMobile) Program. The single-award contract has a one-year base period of performance, four one-year options and a total contract value of more than $108 million if all options are exercised. Work will be performed in Charleston, S.C., and Patuxent River, Md.

The TacMobile Program includes ground support  for “pre-flight mission planning, in-flight data processing, and post-flight data processing and analysis for maritime patrol aircraft in performance of anti-submarine warfare and intelligence, surveillance and reconnaissance missions”.

As part of the deal, SAIC will provide integration and testing of TacMobile hardware, engineering services for maintenance and support of currently fielded TacMobile systems, and design engineering services to support future system upgrades and technical refreshes.

“SAIC has a long history of supporting TacMobile systems and we are pleased to be selected by SPAWAR for this important contract, ” said Debbie James, SAIC senior vice president and business unit general manager. “The services we provide will support evolving operational requirements, aircraft assets, and data sharing requirements while helping to reduce costs through efficient integration of new capabilities.”

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.